Oftalmo MD
Sources: the KBO register on 22-11-2026; the National Bank, 2021 annual accounts filed on 20-03-2022; the Belgian Official Gazette, latest deed of 23-12-2022.
- Base your decision on your own payment experience with the company or on securities.
Grounds
the facts the verdict rests on, each with its source- In 2021, Oftalmo MD made a loss of €2.1m.Annual accounts 2021 page 2
- Equity stands at €7.6m, or 99.1% of the balance sheet total of €7.6m.Annual accounts 2021 page 2
- Cash rose from €25,483 to €382,267. Debts due within one year fell from €93,144 to €3,686.Annual accounts 2020 and 2021 page 2
- Of the €69,114 of debt, €65,428 runs for more than a year.Annual accounts 2021, notes page 2
- The 2022 annual accounts were due at the National Bank by 31-07-2023. 1,210 days later they are not there yet.National Bank page 4
Representation
The signing rule is in the deed of 23-12-2022.
Articles of association, Belgian Official Gazette of 23-12-2022, deed 22386443
Ownership
is mandate holder. According to the deed of 03-01-2012, holds all the shares.
Deed of 23-12-2022, deed 12001687
Financial situation
Annual accounts 2018 to 2021, as filed with the National Bank
Gross margin and net resultin €m
Equity and debtsin €m
Cashin €m
| Financial year | 2018 | 2019 | 2020 | 2021 | Trend |
|---|---|---|---|---|---|
| Results | |||||
| Gross margin | €736,850 | €671,907 | €842,833 | €801,556 | |
| Operating result | €597,964 | €576,348 | €797,023 | €759,842 | |
| Net result | €380,998 | €2.2m | €1.2m | -€2.1m | |
| Balance sheet at the closing date | |||||
| Equity | €6.3m | €8.4m | €9.6m | €7.6m | |
| Debts | €134,244 | €247,796 | €158,572 | €69,114 | |
| Debts due after more than one year | €64,428 | €65,428 | €65,428 | €65,428 | |
| Debts due within one year | €69,816 | €182,368 | €93,144 | €3,686 | |
| Cash | €76,981 | €388,168 | €25,483 | €382,267 | |
| Balance sheet total | €6.4m | €8.7m | €9.8m | €7.6m | |
| Ratios | |||||
| Solvency | 97.9% | 97.1% | 98.4% | 99.1% | |
| Liquidity | 20.41 | 20.27 | 51.79 | - | |
Source: Annual accounts 2021, abbreviated format, filed on 20-03-2022 (2022-08100440); Annual accounts 2020, abbreviated format, filed on 27-07-2021 (2021-40500111); Annual accounts 2018 to 2019, filed from 22-07-2019 to 30-10-2020 (2019-36300049, 2020-66500207).
The operating result of 2021 is €759,842, the net result a loss of €2.1m.
Debts fell by €89,458 in 2021.
Board, signature and ownership
Position on 22-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
The signing rule is in the deed of 23-12-2022.
Articles of association, Belgian Official Gazette of 23-12-2022, deed 22386443
Board
one director in officealso sits on the boards of 2 other companies.
Ownership and group
Shareholders
is mandate holder. is mandate holder. According to the deed of 03-01-2012, holds all the shares.
Deed of 23-12-2022, deed 12001687
Board changes
changes role from sole director to manager. “De uitoefening van de geneeskunde met specialisatie oftalmologie, door de artsenvennoten die in het kader van…” (deed in Dutch). Legal-form conversion: from private limited company to general partnership. Partner: (mandate holder).
Gazette, deed 22386443reappointed as director. General meeting of 17-12-2021.
Gazette, deed 22015506Events and comparison
The latest events, newest first
Annual accounts 2021 filed, 133 days before the deadline.
NBB filingWeakest financial year. The net result drops to -€2.1m, the lowest from 2012 to 2021.
FinancialLiquidity more than 28 times. The current ratio rises from 51.79 to 1490.09. Short-term debt falls from €93,144 to €3,686.
FinancialAnnual accounts 2020 filed, 4 days before the deadline.
NBB filingLiquidity more than doubled. The current ratio rises from 20.27 to 51.79. Short-term debt falls from €182,368 to €93,144.
FinancialAnnual accounts 2019 filed, 91 days late.
NBB filingHighest result from 2012 to 2021. The net result of €2.2m is the highest of those years.
FinancialAnnual accounts 2018 filed, 9 days before the deadline.
NBB filingAnnual accounts 2017 filed, 7 days before the deadline.
NBB filingAnnual accounts 2016 filed, 14 days before the deadline.
NBB filingLiquidity more than 69 times. The current ratio rises from 27.86 to 1948.10. Short-term debt falls from €18,308 to €312.
FinancialAnnual accounts 2015 filed, 10 days before the deadline.
NBB filingLiquidity more than 7 times. The current ratio rises from 3.86 to 27.86. Short-term debt falls from €24,286 to €18,308.
FinancialEquity above €5m. With a profit in every financial year since 2012, equity grows to €5.8m.
FinancialOther findings
Peppol
Reachable for e-invoices since 13-12-2025, under 0208:0842018396.
Sanctions lists
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 22-11-2026 | KBO 0842.018.396 |
| National Bank of Belgium | Annual accounts 2021, abbreviated format | 20-03-2022 | 2022-08100440 |
| National Bank of Belgium | Annual accounts 2020, abbreviated format | 27-07-2021 | 2021-40500111 |
| National Bank of Belgium | Annual accounts 2018 to 2019 | 22-07-2019 to 30-10-2020 | 2019-36300049, 2020-66500207 |
| Belgian Official Gazette | Articles of association with the signing rule | 23-12-2022 | deed 22386443 |
| Belgian Official Gazette | Board | 03-02-2022 | deed 22015506 |
| Belgian Official Gazette | All shares held by one shareholder | 03-01-2012 | deed 12001687 |
| Peppol Directory | Registration for e-invoices | 13-12-2025 | 0208:0842018396 |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 19-11-2026 | |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 21-11-2026 | bankruptcy model of 21 November 2026 |
Method
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 21 November 2026, computed on 21-11-2026.
The scores and ratios are Checked's own calculations, not a credit decision.